Retinal Disease in Rpe65-Deficient Mice: Comparison to Human Leber Congenital Amaurosis Due to RPE65 Mutations
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
PURPOSE: To quantify the retinal disease in Rpe65-deficient mice across a wide age span and compare the results to those in humans with Leber congenital amaurosis (LCA) caused by RPE65 mutations. METHODS: Full-field electroretinograms (ERGs) were recorded from wild-type (C57BL/6; Rpe65(+/+)) and Rpe65(-/-) mice at ages ranging from ∼1 month to 2 years. A physiologically based model of rod phototransduction activation was used to determine photoreceptor (P3) cell components of ERG photoresponses. A bipolar (P2) cell component was also derived. Photoreceptor and inner retinal thickness measurements were made by using optical coherence tomography in human RPE65-LCA. RESULTS: Age-related declines in ERG photoreceptor and bipolar amplitudes were present in the Rpe65(-/-) mouse. The loss of photoresponse amplitude with age in the mutant mice paralleled reported losses of photoreceptor nuclear layer thickness over the same age range. Unexpectedly, the early activation phase of photoresponses in Rpe65(-/-) mice accelerated with age as amplitude decreased; this was not a feature of Rpe65(+/+) mice. Inner retinal dysfunction increased with age in the mutant mice. Human RPE65-LCA patients had retinal degeneration and loss of photoreceptors in the first decade of life. Unlike the mouse model, there were no examples of a normal photoreceptor complement. Abnormal thickening of the inner retina occurred with increasing loss of photoreceptors. CONCLUSIONS: The differences in time course of murine and human RPE65-deficiency diseases suggests that preclinical efficacy testing of therapeutic modalities would be most informative when the murine disease becomes comparable to early human disease, toward the end of the first year of life in Rpe65(-/-) mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For RPE65 the severity of disease has been associated with the degree of residual enzymatic activity.274,281,557”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [557]
Citations
Cites
Human photoreceptor topography
Curcio, C. A., Sloan, K. R., Kalina, R. E., & Hendrickson, A. E. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902920402 · Cited by 3,167
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Self-citationRpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929
Leber congenital amaurosis: Genes, proteins and disease mechanisms
den Hollander, A. I., Roepman, R., Koenekoop, R. K., & Cremers, F. P. M. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.003 · Cited by 811
Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy
Carter‐Dawson, L. D., & Lavail, M. M. (1979) · Journal of Comparative Neurology · doi:10.1002/cne.901880204 · Cited by 695
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
Self-citationAmplification and kinetics of the activation steps in phototransduction
Pugh, E. N., & Lamb, T. D. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90038-h · Cited by 648
Cited by
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
“as, for example, a murine model.(51) The temptation should be resisted to assume there is a common natural history among humans without measuring it.”
BackgroundSelf-citationCideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Swider, M., Iwabe, S., Roman, A. J., Olivares, M. B., Schwartz, S. B., Komáromy, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218933110 · Cited by 444
“However, accumulating evidence has suggested that human RPE65-LCA, which can show degeneration prenatally or within the first years of life (19, 20), is better modeled at the more advanced disease stages in older animals (3, 21).”
BackgroundSelf-citationChemistry of the Retinoid (Visual) Cycle
Kiser, P. D., Golczak, M., & Palczewski, K. (2014) · Chemical Reviews · doi:10.1021/cr400107q · Cited by 353
Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices
Tremblay, M., Zettel, M. L., Ison, J. R., Allen, P. D., & Majewska, A. K. (2012) · Glia · doi:10.1002/glia.22287 · Cited by 309
“…assays revealed a minimal difference in photic sensitivity between the two strains during young adulthood, in agreement with previous observations (Caruso et al., 2010; Danciger et al., 2007; Williams and Jacobs, 2007), but the two groups separated as performance increased with advancing age in…”
BackgroundResultInfluentialClinical Perspective: Treating RPE65-Associated Retinal Dystrophy
Maguire, A. M., Bennett, J., Aleman, E. M., Leroy, B. P., & Aleman, T. S. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.029 · Cited by 184
“Similar phenotypes (severe ERG abnormalities followed by progressive retinal degenerative changes) were noted in both spontaneous mutant and genetically engineered mouse models with Rpe65 mutations.(13,21,31,37,38)”
Identification of DES1 as a vitamin A isomerase in Müller glial cells of the retina
Kaylor, J. J., Yuan, Q., Cook, J., Sarfare, S., Makshanoff, J., Miu, A., Kim, A., Kim, P., Habib, S., Roybal, C. N., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1114 · Cited by 107
Long-term Structural Outcomes of Late-stage RPE65 Gene Therapy
Gardiner, K. L., Cideciyan, A. V., Swider, M., Dufour, V. L., Sumaroka, A., Komáromy, A. M., Hauswirth, W. W., Iwabe, S., Jacobson, S. G., Beltran, W. A., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.013 · Cited by 67
Self-citationRPE65 gene therapy slows cone loss in Rpe65-deficient dogs
Mowat, F. M., Breuwer, A. R., Bartoe, J. T., Annear, M. J., Zhang, Z., Smith, A. J., Bainbridge, J. W., Petersen‐Jones, S. M., & Ali, R. R. (2012) · Gene Therapy · doi:10.1038/gt.2012.63 · Cited by 70
Román, A. J., Cideciyan, A. V., Wu, V. F., Garafalo, A. V., & Jacobson, S. G. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101000 · Cited by 68
Self-citationJacobson, S. G., Cideciyan, A. V., Alemán, T. S., Sumaroka, A., Román, A. J., Świder, M., Schwartz, S., Banin, E., & Stone, E. M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6127 · Cited by 70
Self-citationKinetic, Energetic, and Mechanical Differences between Dark-State Rhodopsin and Opsin
Kawamura, S., Gerstung, M., Colozo, A. T., Helenius, J. H., Maeda, A., Beerenwinkel, N., Park, P. S. ‐., & Müller, D. J. (2013) · Structure · doi:10.1016/j.str.2013.01.011 · Cited by 57
Dinculescu, A., Estreicher, J., Zenteno, J. C., Alemán, T. S., Schwartz, S., Huang, W., Román, A. J., Sumaroka, A., Li, Q., Deng, W., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.169 · Cited by 43
“Full-field ERGs were elicited in 2-month-old (P14-treated) rd6 mice (n = 5) and wild-type C57BL/6 controls (n = 20; mean age, 3.4 months; age range, 1 to 10 months), using methods previously reported (Roman et al., 2007; Pang et al., 2008; Caruso et al., 2010).”
MethodSelf-citationGene therapy for inherited retinal degenerations: initial successes and future challenges
Gupta, P. R., & Huckfeldt, R. M. (2017) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa7a27 · Cited by 35
Clérin, E., Marussig, M., Sahel, J., & Léveillard, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051625 · Cited by 33
“However, LCA2 patients have retinal degeneration and loss of photoreceptors starting in the first decade of life [25].”
BackgroundImprovement in vision: a new goal for treatment of hereditary retinal degenerations
Jacobson, S. G., Cideciyan, A. V., Aguirre, G. D., Román, A. J., Sumaroka, A., Hauswirth, W. W., & Palczewski, K. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1030393 · Cited by 31
“Only more recently were natural history studies performed in the Rpe65 deficient dogs and mice and results used to decide when to administer treatment that would better approximate the human disease [41,42].”
BackgroundSelf-citationGene Therapy Regenerates Protein Expression in Cone Photoreceptors in Rpe65R91W/R91W Mice
Kostic, C., Crippa, S. V., Pignat, V., Bemelmans, A.-P., Samardzija, M., Grimm, C., Wenzel, A., & Arsenijevic, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016588 · Cited by 26
“Rods degenerate more slowly, with residual function demonstrated up to 24 months [29].”
BackgroundLooking for In Vitro Models for Retinal Diseases
Alfonsetti, M., Castelli, V., d’Angelo, M., Benedetti, E., Allegretti, M., Barboni, B., & Cimini, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910334 · Cited by 31
Nakazawa, M., Hara, A., & Ishiguro, S.-I. (2019) · BioMed Research International · doi:10.1155/2019/8276140 · Cited by 29
“Based on these molecular mechanisms, it is likely that the retinal degeneration in the Rpe65–/– mice demonstrated slow rod degeneration and rapid cone degeneration [11, 13, 59], which mimicked the early stage of human LCA [60].”
BackgroundInfluentialTanabu, R., Sato, K., Monai, N., Yamauchi, K., Gonome, T., Xie, Y., Takahashi, S., Ishiguro, S.-I., & Nakazawa, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210439 · Cited by 26
Oh, A., Foster, M. L., Williams, J. G., Zheng, C., Ru, H., Lunn, K. F., & Mowat, F. M. (2019) · Veterinary Ophthalmology · doi:10.1111/vop.12661 · Cited by 20
Hsu, D., Kwon, J. H., Ng, R., Makita, S., Yasuno, Y., Šarunic, M. V., & Ju, M. J. (2020) · Biomedical Optics Express · doi:10.1364/boe.403209 · Cited by 18
Yusuf, I. H., McClements, M. E., MacLaren, R. E., & Issa, P. C. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108603 · Cited by 16
Harrison, K. R., Reifler, A. N., Chervenak, A. P., & Wong, K. Y. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1815793 · Cited by 14
“acted acutely but potentially had off-target effects, while gene knockout was specific but could have induced developmental changes.(20,21) Nonetheless, these divergent approaches gave the same result, namely, disrupting the retinoid cycle made melanopsin-based responses to 14.”
BackgroundRetinal degeneration in mice expressing the constitutively active G90D rhodopsin mutant
Colozo, A. T., Vasudevan, S., & Park, P. S. ‐. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa008 · Cited by 11
Complementation Test of Rpe65 Knockout and Tvrm148
Wright, C. B., Chrenek, M. A., Foster, S. L., Duncan, T. E., Redmond, T. M., Pardue, M. T., Boatright, J. H., & Nickerson, J. M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12336 · Cited by 10
Genetically modified animal models of hereditary diseases for testing of gene-directed therapy
Polikarpova, A. V., Egorova, T. V., & Bardina, M. V. (2022) · Research Results in Pharmacology · doi:10.3897/rrpharmacology.8.82618 · Cited by 9
“RPE65-/- mice showed a lack of rhodopsin, characteristic electroretinography (ERG) changes, retinal dysfunction, and loss of photoreceptors (Caruso et al. 2010).”
Background
Metadata
- Authors
- Caruso, R. C., Aleman, T. S., Cideciyan, A. V., Roman, A. J., Sumaroka, A., Mullins, C. L., Boye, S. L., Hauswirth, W. W., & Jacobson, S. G.
- Affiliations
- University of Pennsylvania (US)
- From the Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania; and
- University of Florida (US)
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2010-10-01
- Volume
- 51
- Issue
- 10
- Pages
- 5304
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W1973622503
- Cited by
- 26
- References
- 73
- Citations by year
- 2022: 1 · 2021: 3 · 2020: 5 · 2019: 4 · 2017: 1 · 2015: 1 · 2013: 4 · 2012: 3
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- Leber congenital amaurosis, retinal degeneration, photoreceptor loss, rod phototransduction, electroretinogram, inner retinal dysfunction, age-related disease progression, mouse model
- MeSH terms
- Retinoid Isomerohydrolase, Adolescent, Adult, Aging, Animals, Carrier Proteins, Child, Child, Preschool, Dark Adaptation, Electroretinography, Eye Proteins, Humans, Mice, Inbred C57BL, Middle Aged, Mutation, Retinal Degeneration, Time Factors, Vision, Ocular, cis-trans-Isomerases, Photoreceptor Cells, Vertebrate, Tomography, Optical Coherence, Mice, Leber Congenital Amaurosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.